img

Global Coagulation Factor IX Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factor IX Market Insights, Forecast to 2034

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
Global Coagulation Factor IX market is expected to reach to US$ 375 million in 2024, with a positive growth of %, compared with US$ 362 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Coagulation Factor IX industry is evaluated to reach US$ 526 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Coagulation Factor IX market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Coagulation Factor IX market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Segment by Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)

Segment by Application


Adult
Kids

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Coagulation Factor IX plant distribution, commercial date of Coagulation Factor IX, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Coagulation Factor IX introduction, etc. Coagulation Factor IX Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Coagulation Factor IX
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Coagulation Factor IX Product Introduction
1.2 Market by Type
1.2.1 Global Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Market by Application
1.3.1 Global Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Kids
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Coagulation Factor IX Sales Estimates and Forecasts 2018-2029
2.2 Global Coagulation Factor IX Revenue by Region
2.2.1 Global Coagulation Factor IX Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Coagulation Factor IX Revenue by Region (2018-2024)
2.2.3 Global Coagulation Factor IX Revenue by Region (2024-2029)
2.2.4 Global Coagulation Factor IX Revenue Market Share by Region (2018-2029)
2.3 Global Coagulation Factor IX Sales Estimates and Forecasts 2018-2029
2.4 Global Coagulation Factor IX Sales by Region
2.4.1 Global Coagulation Factor IX Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Coagulation Factor IX Sales by Region (2018-2024)
2.4.3 Global Coagulation Factor IX Sales by Region (2024-2029)
2.4.4 Global Coagulation Factor IX Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Coagulation Factor IX Sales by Manufacturers
3.1.1 Global Coagulation Factor IX Sales by Manufacturers (2018-2024)
3.1.2 Global Coagulation Factor IX Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Coagulation Factor IX in 2022
3.2 Global Coagulation Factor IX Revenue by Manufacturers
3.2.1 Global Coagulation Factor IX Revenue by Manufacturers (2018-2024)
3.2.2 Global Coagulation Factor IX Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Coagulation Factor IX Revenue in 2022
3.3 Global Key Players of Coagulation Factor IX, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Coagulation Factor IX Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Coagulation Factor IX, Product Offered and Application
3.8 Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Coagulation Factor IX Sales by Type
4.1.1 Global Coagulation Factor IX Historical Sales by Type (2018-2024)
4.1.2 Global Coagulation Factor IX Forecasted Sales by Type (2024-2029)
4.1.3 Global Coagulation Factor IX Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Factor IX Revenue by Type
4.2.1 Global Coagulation Factor IX Historical Revenue by Type (2018-2024)
4.2.2 Global Coagulation Factor IX Forecasted Revenue by Type (2024-2029)
4.2.3 Global Coagulation Factor IX Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Factor IX Price by Type
4.3.1 Global Coagulation Factor IX Price by Type (2018-2024)
4.3.2 Global Coagulation Factor IX Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Coagulation Factor IX Sales by Application
5.1.1 Global Coagulation Factor IX Historical Sales by Application (2018-2024)
5.1.2 Global Coagulation Factor IX Forecasted Sales by Application (2024-2029)
5.1.3 Global Coagulation Factor IX Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Factor IX Revenue by Application
5.2.1 Global Coagulation Factor IX Historical Revenue by Application (2018-2024)
5.2.2 Global Coagulation Factor IX Forecasted Revenue by Application (2024-2029)
5.2.3 Global Coagulation Factor IX Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Factor IX Price by Application
5.3.1 Global Coagulation Factor IX Price by Application (2018-2024)
5.3.2 Global Coagulation Factor IX Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Coagulation Factor IX Market Size by Type
6.1.1 US & Canada Coagulation Factor IX Sales by Type (2018-2029)
6.1.2 US & Canada Coagulation Factor IX Revenue by Type (2018-2029)
6.2 US & Canada Coagulation Factor IX Market Size by Application
6.2.1 US & Canada Coagulation Factor IX Sales by Application (2018-2029)
6.2.2 US & Canada Coagulation Factor IX Revenue by Application (2018-2029)
6.3 US & Canada Coagulation Factor IX Market Size by Country
6.3.1 US & Canada Coagulation Factor IX Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Coagulation Factor IX Sales by Country (2018-2029)
6.3.3 US & Canada Coagulation Factor IX Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Coagulation Factor IX Market Size by Type
7.1.1 Europe Coagulation Factor IX Sales by Type (2018-2029)
7.1.2 Europe Coagulation Factor IX Revenue by Type (2018-2029)
7.2 Europe Coagulation Factor IX Market Size by Application
7.2.1 Europe Coagulation Factor IX Sales by Application (2018-2029)
7.2.2 Europe Coagulation Factor IX Revenue by Application (2018-2029)
7.3 Europe Coagulation Factor IX Market Size by Country
7.3.1 Europe Coagulation Factor IX Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Coagulation Factor IX Sales by Country (2018-2029)
7.3.3 Europe Coagulation Factor IX Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Coagulation Factor IX Market Size
8.1.1 China Coagulation Factor IX Sales (2018-2029)
8.1.2 China Coagulation Factor IX Revenue (2018-2029)
8.2 China Coagulation Factor IX Market Size by Application
8.2.1 China Coagulation Factor IX Sales by Application (2018-2029)
8.2.2 China Coagulation Factor IX Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Coagulation Factor IX Market Size by Type
9.1.1 Asia Coagulation Factor IX Sales by Type (2018-2029)
9.1.2 Asia Coagulation Factor IX Revenue by Type (2018-2029)
9.2 Asia Coagulation Factor IX Market Size by Application
9.2.1 Asia Coagulation Factor IX Sales by Application (2018-2029)
9.2.2 Asia Coagulation Factor IX Revenue by Application (2018-2029)
9.3 Asia Coagulation Factor IX Sales by Region
9.3.1 Asia Coagulation Factor IX Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Coagulation Factor IX Revenue by Region (2018-2029)
9.3.3 Asia Coagulation Factor IX Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Coagulation Factor IX Market Size by Type
10.1.1 Middle East, Africa and Latin America Coagulation Factor IX Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Coagulation Factor IX Market Size by Application
10.2.1 Middle East, Africa and Latin America Coagulation Factor IX Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Coagulation Factor IX Sales by Country
10.3.1 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Coagulation Factor IX Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Information
11.2.2 CSL Behring Overview
11.2.3 CSL Behring Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Behring Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Behring Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novo Nordisk Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Information
11.5.2 Bioverativ Overview
11.5.3 Bioverativ Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bioverativ Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bioverativ Recent Developments
11.6 Sanquin
11.6.1 Sanquin Company Information
11.6.2 Sanquin Overview
11.6.3 Sanquin Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sanquin Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanquin Recent Developments
11.7 Takeda
11.7.1 Takeda Company Information
11.7.2 Takeda Overview
11.7.3 Takeda Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Takeda Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Recent Developments
11.8 Baxter
11.8.1 Baxter Company Information
11.8.2 Baxter Overview
11.8.3 Baxter Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Baxter Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Baxter Recent Developments
11.9 Aptevo
11.9.1 Aptevo Company Information
11.9.2 Aptevo Overview
11.9.3 Aptevo Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Aptevo Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aptevo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Coagulation Factor IX Industry Chain Analysis
12.2 Coagulation Factor IX Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Coagulation Factor IX Production Mode & Process
12.4 Coagulation Factor IX Sales and Marketing
12.4.1 Coagulation Factor IX Sales Channels
12.4.2 Coagulation Factor IX Distributors
12.5 Coagulation Factor IX Customers
13 Market Dynamics
13.1 Coagulation Factor IX Industry Trends
13.2 Coagulation Factor IX Market Drivers
13.3 Coagulation Factor IX Market Challenges
13.4 Coagulation Factor IX Market Restraints
14 Key Findings in The Global Coagulation Factor IX Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor IX (Plasma Derived)
Table 3. Major Manufacturers of Coagulation Factor IX (Recombinant)
Table 4. Global Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Coagulation Factor IX Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Coagulation Factor IX Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Coagulation Factor IX Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Coagulation Factor IX Revenue Market Share by Region (2018-2024)
Table 9. Global Coagulation Factor IX Revenue Market Share by Region (2024-2029)
Table 10. Global Coagulation Factor IX Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Coagulation Factor IX Sales by Region (2018-2024) & (K Units)
Table 12. Global Coagulation Factor IX Sales by Region (2024-2029) & (K Units)
Table 13. Global Coagulation Factor IX Sales Market Share by Region (2018-2024)
Table 14. Global Coagulation Factor IX Sales Market Share by Region (2024-2029)
Table 15. Global Coagulation Factor IX Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Coagulation Factor IX Sales Share by Manufacturers (2018-2024)
Table 17. Global Coagulation Factor IX Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Coagulation Factor IX Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Coagulation Factor IX, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Coagulation Factor IX Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor IX as of 2022)
Table 23. Global Key Manufacturers of Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Coagulation Factor IX, Product Offered and Application
Table 25. Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 28. Global Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 29. Global Coagulation Factor IX Sales Share by Type (2018-2024)
Table 30. Global Coagulation Factor IX Sales Share by Type (2024-2029)
Table 31. Global Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Coagulation Factor IX Revenue Share by Type (2018-2024)
Table 34. Global Coagulation Factor IX Revenue Share by Type (2024-2029)
Table 35. Coagulation Factor IX Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Coagulation Factor IX Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 38. Global Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 39. Global Coagulation Factor IX Sales Share by Application (2018-2024)
Table 40. Global Coagulation Factor IX Sales Share by Application (2024-2029)
Table 41. Global Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Coagulation Factor IX Revenue Share by Application (2018-2024)
Table 44. Global Coagulation Factor IX Revenue Share by Application (2024-2029)
Table 45. Coagulation Factor IX Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Coagulation Factor IX Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Coagulation Factor IX Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Coagulation Factor IX Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Coagulation Factor IX Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Coagulation Factor IX Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Coagulation Factor IX Sales by Country (2024-2029) & (K Units)
Table 60. Europe Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 61. Europe Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 62. Europe Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 65. Europe Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 66. Europe Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Coagulation Factor IX Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Coagulation Factor IX Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Coagulation Factor IX Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Coagulation Factor IX Sales by Country (2018-2024) & (K Units)
Table 72. Europe Coagulation Factor IX Sales by Country (2024-2029) & (K Units)
Table 73. China Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 74. China Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 75. China Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 78. China Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 79. China Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 82. Asia Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 83. Asia Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 86. Asia Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 87. Asia Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Coagulation Factor IX Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Coagulation Factor IX Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Coagulation Factor IX Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Coagulation Factor IX Sales by Region (2018-2024) & (K Units)
Table 93. Asia Coagulation Factor IX Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Coagulation Factor IX Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Coagulation Factor IX Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Coagulation Factor IX Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Coagulation Factor IX Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Coagulation Factor IX Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Coagulation Factor IX Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Coagulation Factor IX Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. CSL Behring Company Information
Table 113. CSL Behring Description and Major Businesses
Table 114. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. CSL Behring Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Behring Recent Developments
Table 117. Grifols Company Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Grifols Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Novo Nordisk Company Information
Table 123. Novo Nordisk Description and Major Businesses
Table 124. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Novo Nordisk Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novo Nordisk Recent Developments
Table 127. Bioverativ Company Information
Table 128. Bioverativ Description and Major Businesses
Table 129. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Bioverativ Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Bioverativ Recent Developments
Table 132. Sanquin Company Information
Table 133. Sanquin Description and Major Businesses
Table 134. Sanquin Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sanquin Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sanquin Recent Developments
Table 137. Takeda Company Information
Table 138. Takeda Description and Major Businesses
Table 139. Takeda Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Takeda Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Takeda Recent Developments
Table 142. Baxter Company Information
Table 143. Baxter Description and Major Businesses
Table 144. Baxter Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Baxter Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Baxter Recent Developments
Table 147. Aptevo Company Information
Table 148. Aptevo Description and Major Businesses
Table 149. Aptevo Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Aptevo Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Aptevo Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Coagulation Factor IX Distributors List
Table 155. Coagulation Factor IX Customers List
Table 156. Coagulation Factor IX Market Trends
Table 157. Coagulation Factor IX Market Drivers
Table 158. Coagulation Factor IX Market Challenges
Table 159. Coagulation Factor IX Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor IX Product Picture
Figure 2. Global Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Coagulation Factor IX Market Share by Type in 2022 & 2029
Figure 4. Coagulation Factor IX (Plasma Derived) Product Picture
Figure 5. Coagulation Factor IX (Recombinant) Product Picture
Figure 6. Global Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Coagulation Factor IX Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Kids
Figure 10. Coagulation Factor IX Report Years Considered
Figure 11. Global Coagulation Factor IX Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Coagulation Factor IX Revenue 2018-2029 (US$ Million)
Figure 13. Global Coagulation Factor IX Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Coagulation Factor IX Revenue Market Share by Region (2018-2029)
Figure 15. Global Coagulation Factor IX Sales 2018-2029 ((K Units)
Figure 16. Global Coagulation Factor IX Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Coagulation Factor IX Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Coagulation Factor IX Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Coagulation Factor IX Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Coagulation Factor IX Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Coagulation Factor IX Sales YoY (2018-2029) & (K Units)
Figure 22. China Coagulation Factor IX Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Coagulation Factor IX Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Coagulation Factor IX Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Coagulation Factor IX Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Coagulation Factor IX Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Coagulation Factor IX Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Coagulation Factor IX in the World: Market Share by Coagulation Factor IX Revenue in 2022
Figure 29. Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 31. Global Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 32. Global Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 33. Global Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Coagulation Factor IX Revenue Share by Country (2018-2029)
Figure 39. US & Canada Coagulation Factor IX Sales Share by Country (2018-2029)
Figure 40. U.S. Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 43. Europe Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 44. Europe Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 45. Europe Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 46. Europe Coagulation Factor IX Revenue Share by Country (2018-2029)
Figure 47. Europe Coagulation Factor IX Sales Share by Country (2018-2029)
Figure 48. Germany Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 49. France Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 53. China Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 54. China Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 55. China Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 56. China Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 57. Asia Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 58. Asia Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 59. Asia Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 60. Asia Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 61. Asia Coagulation Factor IX Revenue Share by Region (2018-2029)
Figure 62. Asia Coagulation Factor IX Sales Share by Region (2018-2029)
Figure 63. Japan Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 67. India Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Coagulation Factor IX Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Coagulation Factor IX Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Coagulation Factor IX Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Coagulation Factor IX Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Coagulation Factor IX Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Coagulation Factor IX Sales Share by Country (2018-2029)
Figure 74. Brazil Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Coagulation Factor IX Revenue (2018-2029) & (US$ Million)
Figure 79. Coagulation Factor IX Value Chain
Figure 80. Coagulation Factor IX Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries